Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers is working to close that gap by targeting which men get a critical blood ...

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of ...

Upfront PSMA PET imaging detects hidden metastases in early prostate cancer, altering treatment plans in up to one-third of ...

For men aged 50-69 years who underwent a one-time prostate-specific antigen (PSA) screening for prostate cancer, a lower prostate cancer-specific mortality was observed after 15 years of follow-up, ...

For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Former president Joe Biden’s newly diagnosed prostate cancer, an aggressive form that has spread to his bones, has renewed the debate about who should receive annual screenings for signs of the ...